Neuroprotective effects of bergenin in Alzheimer’s disease: Investigation through molecular docking, in vitro and in vivo studies
- 1 January 2019
- journal article
- research article
- Published by Elsevier in Behavioural Brain Research
- Vol. 356, 18-40
Abstract
No abstract availableKeywords
Funding Information
- Department of Science and Technology
- Department of Biotechnology
- Gujarat Council on Science and Technology (GUJCOST/MRP/15-16/1107)
This publication has 81 references indexed in Scilit:
- Structure-activity Relationships for Bergenin Analogues as ^|^beta;-Secretase (BACE1) InhibitorsJournal of Oleo Science, 2013
- What have we learned from the streptozotocin-induced animal model of sporadic Alzheimer’s disease, about the therapeutic strategies in Alzheimer’s researchJournal of Neural Transmission, 2012
- Acetylcholine and attentionBehavioural Brain Research, 2011
- Cholinergic activation of hippocampal neural stem cells in aged dentate gyrusHippocampus, 2011
- Neuropathology of Alzheimer's DiseaseMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010
- Does Alzheimer's disease begin in the brainstem?Neuropathology and Applied Neurobiology, 2009
- Cell signaling pathways in the mechanisms of neuroprotection afforded by bergamot essential oil against NMDA‐induced cell death in vitroBritish Journal of Pharmacology, 2007
- Morris water maze: procedures for assessing spatial and related forms of learning and memoryNature Protocols, 2006
- Alzheimer‐like changes in protein kinase B and glycogen synthase kinase‐3 in rat frontal cortex and hippocampus after damage to the insulin signalling pathwayJournal of Neurochemistry, 2006
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991